Jeehyun Yoon

Jeehyun Yoon

Auto-generated profile, based on publicly available information

Jeehyun Yoon

Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
JYJeehyun Yoon
Jeehyun Yoon
OGOleg V. Grinchuk
Oleg V. Grinchuk
RTRoberto Tirado-Magallanes
Roberto Tirado-Magallanes
ZNZhen Kai Ngian
Zhen Kai Ngian
ETEmmy Xue Yun Tay
Emmy Xue Yun Tay
DODerrick Sek Tong Ong
Derrick Sek Tong Ong
The histone variant H2AZ is overexpressed in diverse cancer types where it facilitates the accessibility of transcriptional regulators to the promoters of cell cycle genes. However, the molecular basis for its dysregulation in cancer remains unknown. Here, we report that glioblastomas (GBM) and glioma stem cells (GSCs) preferentially overexpress H2AZ for their proliferation, stemness and tumorigenicity. Chromatin accessibility analysis of H2AZ2 depleted GSC revealed that E2F1 occupies the enhancer region within H2AZ2 gene promoter, thereby activating H2AZ2 transcription. Exploration of other H2AZ2 transcriptional activators using a customized “anti-H2AZ2” query signature for connectivity map analysis identified STAT3. Co-targeting E2F and STAT3 synergistically reduced the levels of H2AZ, histone 3 lysine 27 acetylation (H3K27ac) and cell cycle gene transcription, indicating that E2F1 and STAT3 synergize to activate H2AZ gene transcription in GSCs. Remarkably, an E2F/STAT3 inhibitor combination durably suppresses GSC tumorigenicity in an orthotopic GBM xenograft model. In glioma patients, high STAT3 signaling is associated with high E2F1 and H2AZ2 expression. Thus, GBM has uniquely opted the use of E2F1- and STAT3-containing “enhanceosomes” that integrate multiple signaling pathways to achieve H2AZ gene activation, supporting a translational path for the E2F/STAT3 inhibitor combination to be applied in GBM treatment.

3 September 2021 in Science Advances
Verified
Journal Article
Open access
JYJeehyun Yoon
Jeehyun Yoon
OGOleg V. Grinchuk
Oleg V. Grinchuk
SKSrinivasaraghavan Kannan
Srinivasaraghavan Kannan
MAMelgious Jin Yan Ang
Melgious Jin Yan Ang
ZLZhenglin Li
Zhenglin Li
DODerrick Sek Tong Ong
Derrick Sek Tong Ong
An antifungal drug reveals a dependency of glioblastoma on intracellular biotin distribution.

19 July 2023 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
YCYou Heng Chuah
You Heng Chuah
ETEmmy Xue Yun Tay
Emmy Xue Yun Tay
OGOleg V. Grinchuk
Oleg V. Grinchuk
JYJeehyun Yoon
Jeehyun Yoon
JFJia Feng
Jia Feng
DODerrick Sek Tong Ong
Derrick Sek Tong Ong
MAD2 is a spindle assembly checkpoint protein that participates in the formation of mitotic checkpoint complex, which blocks mitotic progression. RNF8, an established DNA damage response protein, has been implicated in mitotic checkpoint regulation but its exact role remains poorly understood. Here, RNF8 proximity proteomics uncovered a role of RNF8-MAD2 in generating the mitotic checkpoint signal. Specifically, RNF8 competes with a small pool of p31comet for binding to the closed conformer of MAD2 via its RING domain, while CAMK2D serves as a molecular scaffold to concentrate the RNF8-MAD2 complex via transient/weak interactions between its p-Thr287 and RNF8’s FHA domain. Accordingly, RNF8 overexpression impairs glioma stem cell (GSC) mitotic progression in a FHA- and RING-dependent manner. Importantly, low RNF8 expression correlates with inferior glioma outcome and RNF8 overexpression impedes GSC tumorigenicity. Last, we identify PLK1 inhibitor that mimics RNF8 overexpression using a chemical biology approach, and demonstrate a PLK1/HSP90 inhibitor combination that synergistically reduces GSC proliferation and stemness. Thus, our study has unveiled a previously unrecognized CAMK2D-RNF8-MAD2 complex in regulating mitotic checkpoint with relevance to gliomas, which is therapeutically targetable.

2 January 2026 in Science Advances
Verified
Journal Article
Open access
YLYajing Liang
Yajing Liang
OGOleg V. Grinchuk
Oleg V. Grinchuk
NCNadia Omega Cipta
Nadia Omega Cipta
YZYingying Zeng
Yingying Zeng
YCYou Heng Chuah
You Heng Chuah
DODerrick Sek Tong Ong
Derrick Sek Tong Ong
Impaired neural stem cell (NSC) proliferation/activation is associated with brain aging, but the underlying mechanisms remain poorly understood. Here, we unexpectedly find that DMTF1, a transcription factor that regulates the Arf/p53 axis in cancer, is down-regulated in the NSCs of a premature aging model driven by telomerase deficiency. DMTF1 up-regulation was able to rescue the impaired proliferation of telomere dysfunctional NSCs. Mechanistically, DMTF1 regulates the transcription of Arid2 and Ss18 genes, two subunits of the SWI/SNF complexes that mediate H3K27ac at E2F gene promoters to promote NSC proliferation. Accordingly, Arid2 or Ss18 depletion phenocopies DMTF1 loss in reducing H3K27ac levels, expression of E2F target genes, and NSC proliferation. Thus, our study has identified DMTF1 as a potential therapeutic target to reverse the proliferation defect of aged NSC that is modeled by telomere attrition and unearthed a distinct genetic program controlled by DMTF1 in NSC.